TABLE 3.
Comorbidities captured during the 6-month baseline period in the Integrated Medical Database of National Taiwan University Hospital (NTUH-iMD) and the linked National Health Insurance Research Database (NHIRD) among oral hypoglycemic agent users with continuous 6-month baseline and 24-month follow-up data (n = 3,845).
| Condition† | NTUH-iMD | NHIRD | Absolute standardized difference |
|---|---|---|---|
| N (%) | N (%) | ||
| Myocardial infarction | <5 (<0.1) | 114 (3.0) | 0.24 |
| Congestive heart failure | 9 (0.2) | 244 (6.4) | 0.35 |
| Peripheral vascular disease | 5 (0.1) | 109 (2.8) | 0.23 |
| Cerebrovascular disease | 24 (0.6) | 546 (14.2) | 0.54 |
| Dementia | 5 (0.1) | 112 (2.9) | 0.23 |
| Chronic pulmonary disease | 13 (0.3) | 431 (11.2) | 0.48 |
| Rheumatologic disease | <5 (<0.1) | 46 (1.2) | 0.15 |
| Peptic ulcer | 11 (0.3) | 398 (10.4) | 0.46 |
| Liver disease | 10 (0.3) | 298 (7.8) | 0.39 |
| Mild liver disease | 10 (0.3) | 298 (7.8) | 0.39 |
| Moderate or severe liver disease | <5 (<0.1) | 21 (0.6) | 0.10 |
| Diabetes | 121 (3.2) | 2108 (54.8) | 1.39 |
| Diabetes without chronic complication | 119 (3.1) | 2070 (53.8) | 1.36 |
| Diabetes with chronic complication | <5 (<0.1) | 312 (8.1) | 0.41 |
| Hemiplegia or paraplegia | 0 (0.0) | 31 (0.8) | 0.13 |
| Renal disease | 13 (0.3) | 301 (7.8) | 0.39 |
| Malignancy | 30 (0.8) | 576 (15.0) | 0.55 |
| Metastatic solid tumor | <5 (<0.1) | 48 (1.3) | 0.15 |
| AIDS/HIV | 0 (0.0) | <5 (<0.1) | 0.04 |
†Primary and secondary diagnoses from any visit.